Assured Guaranty Ltd. (AGO)
NYSE: AGO
· Real-Time Price · USD
87.77
0.38 (0.43%)
At close: May 13, 2025, 3:59 PM
87.69
-0.09%
After-hours: May 13, 2025, 05:53 PM EDT
Assured Guaranty Revenue Breakdown
Period Ending | Dec 31, 2024 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|---|
Financial Guarantee Insurance Product Line Revenue | 4.18B | 3.51B | 3.41B | 3.34B | 3.77B |
Financial Guarantee Insurance Product Line Revenue Growth | +19.02% | +3.08% | +1.94% | -11.35% | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | n/a | 49M | 47M | 48M | 58M | 52M | 47M | 70M | 82M | 69M | 57M | 59M | 73M | 57M | 59M | 54M | 60M | 61M | 57M | 46M | 64M | 60M | 38M | 39M | 41M | 152M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling, General, and Administrative Revenue Growth | -100.00% | +4.26% | -2.08% | -17.24% | +11.54% | +10.64% | -32.86% | -14.63% | +18.84% | +21.05% | -3.39% | -19.18% | +28.07% | -3.39% | +9.26% | -10.00% | -1.64% | +7.02% | +23.91% | -28.12% | +6.67% | +57.89% | -2.56% | -4.88% | -73.03% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |